Funding for this research was provided by:
National Natural Science Foundation of China (12375335)
Article History
Received: 9 October 2024
Revised: 16 December 2024
Accepted: 19 December 2024
First Online: 23 January 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. This study was approved by the institutional review board at Beijing Cancer Hospital on 2 March 2021 (approval code: 2021KT32).
: Individual consent for this retrospective analysis was waived.
: Authors consent to publish this article, and the manuscript is approved by all authors for submission.
: The authors declare no competing interests.